Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Musculoskeletal  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Osteoarthritis Clinical Trials

A listing of Osteoarthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (574) clinical trials

Arthrititic pain of the knee, one knee worse than the other

Phase N/A

This phase 2 study is a placebo-controlled, double-blind, parallel group study of four concentrations of SM04690 (0.03, 0.07, 0.15, and 0.23 mg per 2 mL injection) injected intraarticularly (IA) into the target knee joint of subjects with moderately to severely symptomatic osteoarthritis (OA). Based on previous studies of SM04690, key ...

Phase

This study is an open-label, repeat administration design of 40 mg FX006. The study will be conducted in male and female patients ≥ years of age with symptomatic OA of the knee. Eligible patients will be offered participation to receive an initial IA injection of FX006 administered to the index ...

Phase

A clinical research study is being conducted for osteoarthritis of the knee Study Flyer

Phase N/A

A Randomized, Double-Blind, Placebo-controlled trial to assess the efficacy and safety of AXS-02 (disodium zoledronate tetrahydrate) administered orally to subjects with knee osteoarthritis associated with bone marrow lesions.

Phase N/A

The purpose of this study is to evaluate the safety and effectiveness of a new experimental medication for the treatment of moderate to severe osteoarthritis of the hip or knee.

Phase

This clinical research study is evaluating a new investigational medication for moderate to severe pain of the knee caused by osteoarthritis.

Phase

This is A randomized, double-blind, placebo-controlled, multicenter, parallel-group, study of the efficacy and safety of Tanezumab when administered by SC injection for 16 weeks compared to placebo in subjects osteoarthritis of the Knee or hip. Subjects will receive a total of two injections, separated by 8 weeks.

Phase

Participation in this research study of an investigational drug could last up to 18 months and include approximately 17 clinic visits. Reimbursement may be provided to qualified participants for time and travel.

Phase N/A

This is a randomized, double-blind, placebo-controlled, multicenter, parallel-group, Phase 3 study of the efficacy and safety of tanezumab when administered by SC injection for 16 weeks compared to placebo in subjects with osteoarthritis of the knee or hip.

Phase